Back
Cathay General Bancorp Vs. Novartis AG Industry Stock Comparison
Buy
55
CATY
Cathay General Bancorp
Last Price:
$43.97
Seasonality Move:
1.55%
Buy
71
NVSEF
Novartis AG
Last Price:
$116.60
Seasonality Move:
6.56%
Buy
55
Cathay General Bancorp (CATY)
is a Buy
Is Cathay General Bancorp a Buy, Sell or Hold?
-
The current Cathay General Bancorp [CATY] share price is $44.25. The Score for CATY is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
-
CATY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
71
Novartis AG (NVSEF)
is a Buy
Is Novartis AG a Buy, Sell or Hold?
-
The current Novartis AG [NVSEF] share price is $116.60. The Score for NVSEF is 71, which is 42% above its historic median score of 50, and infers lower risk than normal.
-
NVSEF is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
CATY Stock Price Chart
What is Cathay General Bancorp's stock price today?
-
The Cathay General Bancorp share price today is $44.25Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CATY is experiencing buying pressure, which is a positive indicator for future bullish movement.
NVSEF Stock Price Chart
What is Novartis AG's stock price today?
-
The Novartis AG share price today is $116.60Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NVSEF is experiencing slight buying pressure.
CATY Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.84 | Sell |
| Relative Strength Index (14 RSI): | 46.95 | Sell |
| Chaikin Money Flow: | 171261 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (43.41 - 46.55) | Sell |
| Bollinger Bands (100): | (45.12 - 50.64) | Sell |
NVSEF Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 1.84 | Buy |
| Relative Strength Index (14 RSI): | 61.26 | Buy |
| Chaikin Money Flow: | 0 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (107.1 - 113.78) | Buy |
| Bollinger Bands (100): | (98.55 - 109.41) | Buy |
CATY Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 43.51 | Buy |
| 20-day SMA: | 44.55 | Sell |
| 50-day SMA: | 46.11 | Sell |
| 200-day SMA: | 44.46 | Sell |
| 8-day EMA: | 43.74 | Buy |
| 20-day EMA: | 44.42 | Sell |
| 50-day EMA: | 45.74 | Sell |
| 200-day EMA: | 44.72 | Sell |
NVSEF Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 110.96 | Buy |
| 20-day SMA: | 111.23 | Buy |
| 50-day SMA: | 106.01 | Buy |
| 200-day SMA: | 106.77 | Buy |
| 8-day EMA: | 112.31 | Buy |
| 20-day EMA: | 110.66 | Buy |
| 50-day EMA: | 107.55 | Buy |
| 200-day EMA: | 104.74 | Buy |
Cathay General Bancorp Earnings Growth & CATY Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.15 per share, an increase next quarter of $0.02 per share, an increase this year of $0.20 per share, and an increase next year of $0.53 per share.
Novartis AG Earnings Growth & NVSEF Earnings Dates
-
Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Cathay General Bancorp Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Novartis AG Technical Analysis
| Mar 11 | Mar 12 | Mar 13 | Mar 14 | Mar 17 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 24 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar | ||||||||||
| 11 | 12 | 13 | 14 | 17 | 18 | 19 | 20 | 21 | 24 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||